More Sobriety Checkpoints Needed In Thailand

Published Dec 17, 2012
Phatthalung, Thailand - Alcohol-related road traffic injuries are a leading cause of death in Thailand. Each day, 35-43 Thais leave home and never return. A study, “Cost-Effectiveness of Interventions for Reducing Road Traffic Injuries Related to Driving under the Influence of Alcohol,” published in Value in Health, aimed to determine if interventions to reduce road traffic injuries caused by driving under the influence of alcohol are cost-effective - i.e. provide good value for money. The authors considered alcohol-related road traffic crash victims who were injured, disabled, or died. Intervention effectiveness was derived from published reviews and a study in Thailand. Random breath testing (RBT), selective breath testing (SBT) and mass media campaigns, both current and intervention scenarios, were evaluated. The results suggest that the current mix of mass media campaigns and sobriety checkpoints in Thailand is cost-effective, but also that underinvestment in checkpoints limits their overall effect. Mass media campaigns, RBT and SBT all have the ability to save money from health care treatment costs whilst preventing road traffic injuries and deaths. Principle investigator of the Setting Priorities using Information on Cost-Effectiveness Project, Professor Theo Vos said, “In a developing country such as Thailand, a greater intensity of conducting sobriety checkpoints is recommended. Mass media campaigns and sobriety checkpoints have the potential to reduce alcohol-related injuries and deaths by nearly one quarter.”

Value in Health (ISSN 1098-3015) publishes papers, concepts, and ideas that advance the field of pharmacoeconomics and outcomes research as well as policy papers to help health care leaders make evidence-based decisions. The journal is published bi-monthly and has over 8,000 subscribers (clinicians, decision-makers, and researchers worldwide).

International Society for Pharmacoeconomics and Outcomes Research (ISPOR) is a nonprofit, international, educational and scientific organization that strives to increase the efficiency, effectiveness, and fairness of health care resource use to improve health.

For more information: www.ispor.org

Related Stories

New Research Collection Reveals How Artificial Intelligence Is Reshaping Health Economics

Nov 6, 2025

The PhRMA Foundation and ISPOR announced the publication of a special themed section of research papers that explores the dynamic intersection of artificial intelligence (AI) and health economics and outcomes research (HEOR).

ISPOR Announces 2025 Health Economics and Outcomes Research Award Honorees

Oct 20, 2025

ISPOR announced the recipients of its 2025 Health Economics and Outcomes Research (HEOR) Scientific and Leadership Awards. ISPOR Scientific Awards are designed to foster and recognize excellence and outstanding achievement in HEOR and its Leadership Awards recognize excellence and outstanding leadership in the field.

The Ozempic Paradox: How Spending Billions on Weight-Loss Drug Would Actually Reduce Overall Medicare Costs

Oct 14, 2025

Value in Health, the official journal of ISPOR—The Professional Society for Health Economics and Outcomes Research, announced today the publication of a landmark study by researchers at the University of Washington, Curta, Inc, and the University of North Carolina showing that broad Medicare coverage of semaglutide in diabetes, obesity, and liver disease could generate significant cost savings while delivering substantial health benefits to beneficiaries. The report, “Comprehensive Access to Semaglutide: Clinical and Economic Implications for Medicare,” was published in the October 2025 issue of Value in Health.
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×